The treatment possibilities of patients with relapsed Hodgkin’s lymphoma, stages I and II: descriptive, retrospective study
Închide
Conţinutul numărului revistei
Articolul precedent
Articolul urmator
691 9
Ultima descărcare din IBN:
2022-06-08 10:51
Căutarea după subiecte
similare conform CZU
616-006.441-036-08 (1)
Patologie. Medicină clinică (6850)
SM ISO690:2012
DĂNILĂ, Aliona. The treatment possibilities of patients with relapsed Hodgkin’s lymphoma, stages I and II: descriptive, retrospective study. In: Revista de Ştiinţe ale Sănătăţii din Moldova, 2018, nr. 3(17), pp. 52-60. ISSN 2345-1467.
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Revista de Ştiinţe ale Sănătăţii din Moldova
Numărul 3(17) / 2018 / ISSN 2345-1467

The treatment possibilities of patients with relapsed Hodgkin’s lymphoma, stages I and II: descriptive, retrospective study

CZU: 616-006.441-036-08

Pag. 52-60

Dănilă Aliona
 
Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“
 
Disponibil în IBN: 15 decembrie 2018


Rezumat

Treatment of relapsed Hodgkin’s lymphoma in stages I-II after complete remission remains poorly effective (54.2%-68.0%) and life expectancy over 5 years is 80%.

Cuvinte-cheie
Hodgkin’s lymphoma, relapses, treatment.

Cerif XML Export

<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-69289</cfResPublId>
<cfResPublDate>2018-12-10</cfResPublDate>
<cfVol>17</cfVol>
<cfIssue>3</cfIssue>
<cfStartPage>52</cfStartPage>
<cfISSN>2345-1467</cfISSN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/69289</cfURI>
<cfTitle cfLangCode='RO' cfTrans='o'>The treatment possibilities of patients with relapsed Hodgkin&rsquo;s lymphoma, stages I and II: descriptive, retrospective study</cfTitle>
<cfKeyw cfLangCode='RO' cfTrans='o'>Hodgkin’s lymphoma; relapses; treatment.</cfKeyw>
<cfAbstr cfLangCode='EN' cfTrans='o'><p>Treatment of relapsed Hodgkin&rsquo;s lymphoma in stages I-II after complete remission remains poorly effective (54.2%-68.0%) and life expectancy over 5 years is 80%.</p></cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2018-12-10T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2018-12-10T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-29193</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2018-12-10T24:00:00</cfStartDate>
</cfPers_ResPubl>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-29193</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-29193-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2018-12-10T24:00:00</cfStartDate>
<cfFamilyNames>Dănilă</cfFamilyNames>
<cfFirstNames>Aliona</cfFirstNames>
</cfPersName_Pers>
</cfPers>
</CERIF>